V007-0126 Screening compound: N-{4-[3-(4-tert-butylphenyl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide

V007-0126 Screening compound: N-{4-[3-(4-tert-butylphenyl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide
V007-0126 Screening compound: N-{4-[3-(4-tert-butylphenyl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V007-0126
N-{4-[3-(4-tert-butylphenyl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-0126

Molecular Formula

C25H26N2O2S2 (C25 H26 N2 O2 S2)

Compound Name

N-{4-[3-(4-tert-butylphenyl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide

IUPAC name

N-{4-[3-(4-tert-butylphenyl)-4-oxo-13-thiazolidin-2-yl]phenyl}-2-(thiophen-2-yl)acetamide

SMILES

CC(C)(C)c(cc1)ccc1N(C(c(cc1)ccc1NC(Cc1cccs1)=O)SC1)C1=O

InChI

InChI=1S/C25H26N2O2S2/c1-25(2,3)18-8-12-20(13-9-18)27-23(29)16-31-24(27)17-6-10-19(11-7-17)26-22(28)15-21-5-4-14-30-21/h4-14,24H,15-16H2,1-3H3,(H,26,28)/t24-/m0/s1

InChI Key

CTKAATPAAKYKNL-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD19861456

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.295

Distribution Coefficient, logD

5.295

Water Solubility, LogSw

-5.33

Polar Surface Area

40.029

Acid Dissociation Constant (pKa)

12.36

Base Dissociation Constant (pKb)

1.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.00

V007-0126 in Drug Discovery

Included in Screening Libraries

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V007-0126 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V007-0126?
Check Price and Availability of V007-0126, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V007-0126 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V007-0126
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V007-0126
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V007-0126 available by request